Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1792, Issue 8, 2009, Pages 796-803

  Plotnikov, Egor Y ^a   Chupyrkina, Anastasia A ^a   Pevzner, Irina B ^a   Isaev, Nickolaj K ^a   Zorov, Dmitry B ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Mitochondria; Nitric oxide; Reactive oxygen species; Rhabdomyolysis

Indexed keywords

ANTIOXIDANT; CYCLOSPORIN A; CYTOCHROME C; DEFEROXAMINE; GLYCEROL; MYOGLOBIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; KIDNEY DYSFUNCTION; KIDNEY INJURY; KIDNEY TUBULE; LIPID PEROXIDATION; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MYOGLOBINURIA; NONHUMAN; OXIDATIVE PHOSPHORYLATION UNCOUPLING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SECRETION; RAT; RHABDOMYOLYSIS;

ANIMALS; ANTIOXIDANTS; CELL RESPIRATION; DEFEROXAMINE; FREE RADICAL SCAVENGERS; HUMANS; IRON CHELATING AGENTS; KIDNEY TUBULES; MALE; MALONDIALDEHYDE; MITOCHONDRIA; MYOGLOBIN; MYOGLOBINURIA; NITRIC OXIDE; OXIDATIVE STRESS; PLASTOQUINONE; RATS; RHABDOMYOLYSIS;

EID: 67651109101     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2009.06.005     Document Type: Article

References (50)

1. Roth D., Alarcon F.J., Fernandez J.A., Preston R.A., and Bourgoignie J.J. Acute rhabdomyolysis associated with cocaine intoxication. N. Engl. J. Med. 319 (1988) 673-677
2. Cunningham M. Ecstasy-induced rhabdomyolysis and its role in the development of acute renal failure. Intensive Crit. Care Nurs. 13 (1997) 216-223
3. Bush S.P., and Jansen P.W. Severe rattlesnake envenomation with anaphylaxis and rhabdomyolysis. Ann. Emerg. Med. 25 (1995) 845-848
4. Vanholder R., Sever M.S., Erek E., and Lameire N. Rhabdomyolysis. J. Am. Soc. Nephrol. 11 (2000) 1553-1561
5. Evans M., and Rees A. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?. Drug Safety 25 (2002) 649-663
6. Thompson P.D., Clarkson P., and Karas R.H. Statin-associated myopathy. JAMA 289 (2003) 1681-1690
7. Plotnikov E.Y., Kazachenko A.V., Vyssokikh M.Y., Vasileva A.K., Tcvirkun D.V., Isaev N.K., Kirpatovsky V.I., and Zorov D.B. The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney. Kidney Int. 72 (2007) 1493-1502
8. Oken D.E., Arce M.L., and Wilson D.R. Glycerol-induced hemoglobinuric acute renal failure in the rat. I. Micropuncture study of the development of oliguria. J. Clin. Invest. 45 (1966) 724-735
9. Pelletier R., Nadasdy T., Nadasdy G., Satoskar A., Tewari A.K., Cotrill J., Henry M., Rajab A., and Ferguson R. Acute renal failure following kidney transplantation associated with myoglobinuria in patients treated with rapamycin. Transplantation 82 (2006) 645-650
10. Visweswaran P., and Guntupalli J. Rhabdomyolysis. Crit. Care Clin. 15 (1999) 415-428 ix-x
11. Shah S.V., and Walker P.D. Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am. J. Physiol. 255 (1988) F438-F443
12. Zager R.A. Mitochondrial free radical production induces lipid peroxidation during myohemoglobinuria. Kidney Int. 49 (1996) 741-751
13. Reeder B.J., Sharpe M.A., Kay A.D., Kerr M., Moore K., and Wilson M.T. Toxicity of myoglobin and haemoglobin: oxidative stress in patients with rhabdomyolysis and subarachnoid haemorrhage. Biochem. Soc. Trans. 30 (2002) 745-748
14. Barnes R., Jones M.S., Jones O.T., and Porra R.J. Ferrochelatase and δ-aminolaevulate synthetase in brain, heart, kidney and liver of normal and porphyric rats. The induction of δ-aminolaevulate synthetase in kidney cytosol and mitochondria by allylisopropylacetamide. Biochem. J. 124 (1971) 633-637
15. Zorov D.B., Krasnikov B.F., Kuzminova A.E., Vysokikh M.Y.u., and Zorova L.D. Mitochondria revisited. Alternative functions of mitochondria. Biosci. Rep. 17 (1997) 507-520
16. Ishizuka S., Nagashima Y., Numata M., Yano T., Hagiwara K., Ozasa H., Sone M., Nihei H., and Horikawa S. Regulation and immunohistochemical analysis of stress protein heme oxygenase-1 in rat kidney with myoglobinuric acute renal failure. Biochem. Biophys. Res. Commun. 240 (1997) 93-98
17. Rice-Evans C., Green E., Paganga G., Cooper C., and Wrigglesworth J. Oxidised low density lipoproteins induce iron release from activated myoglobin. FEBS Lett. 326 (1993) 177-182
18. Moore K.P., Holt S.G., Patel R.P., Svistunenko D.A., Zackert W., Goodier D., Reeder B.J., Clozel M., Anand R., Cooper C.E., Morrow J.D., Wilson M.T., Darley-Usmar V., and Roberts II L.J. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J. Biol. Chem. 273 (1998) 31731-31737
19. Gburek J., Birn H., Verroust P.J., Goj B., Jacobsen C., Moestrup S.K., Willnow T.E., and Christensen E.I. Renal uptake of myoglobin is mediated by the endocytic receptors megalin and cubilin. Am. J. Physiol. Renal. Physiol. 285 (2003) F451-F458
20. Birn H., and Christensen E.I. Renal albumin absorption in physiology and pathology. Kidney Int. 69 (2006) 440-449
21. Sharma S., Dimasi D., Broer S., Kumar R., and Della N.G. Heme carrier protein 1 (HCP1) expression and functional analysis in the retina and retinal pigment epithelium. Exp. Cell Res. 313 (2007) 1251-1259
22. Morse D., Lin L., Choi A.M., and Ryter S.W. Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. Free Radic. Biol. Med. 47 (2009) 1-12
23. Zorov D.B., Isaev N.K., Plotnikov E.Y., Zorova L.D., Stelmashook E.V., Vasileva A.K., Arkhangelskaya A.A., and Khrjapenkova T.G. The mitochondrion as janus bifrons. Biochemistry (Mosc.) 72 (2007) 1115-1126
24. Zager R.A., and Foerder C.A. Effects of inorganic iron and myoglobin on in vitro proximal tubular lipid peroxidation and cytotoxicity. J. Clin. Invest. 89 (1992) 989-995
25. Zager R.A., and Burkhart K. Myoglobin toxicity in proximal human kidney cells: roles of Fe, Ca2+, H2O2, and terminal mitochondrial electron transport. Kidney Int. 51 (1997) 728-738
26. Giulivi C., Poderoso J.J., and Boveris A. Production of nitric oxide by mitochondria. J. Biol. Chem. 273 (1998) 11038-11043
27. Brown G.C. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim. Biophys. Acta 1504 (2001) 46-57
28. Zurovsky Y. Models of glycerol-induced acute renal failure in rats. J. Basic Clin. Physiol. Pharmacol. 4 (1993) 213-228
29. Chance B., and Williams G.R. A simple and rapid assay of oxidative phosphorylation. Nature 175 (1955) 1120-1121
30. Mihara M., and Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86 (1978) 271-278
31. Zager R.A., Johnson A.C., and Hanson S.Y. Proximal tubular cytochrome c efflux: determinant, and potential marker, of mitochondrial injury. Kidney Int. 65 (2004) 2123-2134
32. Pollock C.A., and Poronnik P. Albumin transport and processing by the proximal tubule: physiology and pathophysiology. Curr. Opin. Nephrol. Hypertens. 16 (2007) 359-364
33. Tang J., Faustman C., Mancini R.A., Seyfert M., and Hunt M.C. Mitochondrial reduction of metmyoglobin: dependence on the electron transport chain. J. Agric. Food. Chem. 53 (2005) 5449-5455
34. Cooper C.E., Green E.S., Rice-Evans C.A., Davies M.J., and Wrigglesworth J.M. A hydrogen-donating monohydroxamate scavenges ferryl myoglobin radicals. Free Radic. Res. 20 (1994) 219-227
35. Reeder B.J., and Wilson M.T. Desferrioxamine inhibits production of cytotoxic heme to protein cross-linked myoglobin: a mechanism to protect against oxidative stress without iron chelation. Chem. Res. Toxicol. 18 (2005) 1004-1011
36. Skulachev V.P. A biochemical approach to the problem of aging: "megaproject" on membrane-penetrating ions. The first results and prospects. Biochemistry (Mosc.) 72 (2007) 1385-1396
37. Antonenko Y.N., Avetisyan A.V., Bakeeva L.E., Chernyak B.V., Chertkov V.A., Domnina L.V., Ivanova O.Y., Izyumov D.S., Khailova L.S., Klishin S.S., Korshunova G.A., Lyamzaev K.G., Muntyan M.S., Nepryakhina O.K., Pashkovskaya A.A., Pletjushkina O.Y., Pustovidko A.V., Roginsky V.A., Rokitskaya T.I., Ruuge E.K., Saprunova V.B., Severina I.I., Simonyan R.A., Skulachev I.V., Skulachev M.V., Sumbatyan N.V., Sviryaeva I.V., Tashlitsky V.N., Vassiliev J.M., Vyssokikh M.Y., Yaguzhinsky L.S., Zamtyatnin A.A., and Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies. Biochemistry (Mosc.) 73 (2008) 1273-1287
38. Bakeeva L.E., Barskov I.V., Egorov M.V., Isaev N.K., Kapelko V.I., Kazachenko A.V., Kirpatovsky V.I., Kozlovsky S.V., Lakomkin V.L., Levina S.B., Pisarenko O.I., Plotnikov E.Y., Saprunova V.B., Serebryakova L.I., Skulachev M.V., Stelmashook E.V., Studneva I.M., Tskitishvili O.V., Vasilyeva A.K., Victorov I.V., Zorov D.B., and Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke). Biochemistry (Mosc.) 73 (2008) 1288-1299
39. Agapova L.S., Chernyak B.V., Domnina L.V., Dugina V.B., Efimenko A.Y., Fetisova E.K., Ivanova O.Y., Kalinina N.I., Khromova N.V., Kopnin B.P., Kopnin P.B., Korotetskaya M.V., Lichinitser M.R., Lukashev A.L., Pletjushkina O.Y., Popova E.N., Skulachev M.V., Shagieva G.S., Stepanova E.V., Titova E.V., Tkachuk V.A., Vasiliev J.M., and Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells. Biochemistry (Mosc.) 73 (2008) 1300-1316
40. Neroev V.V., Archipova M.M., Bakeeva L.E., Fursova A.Z.h., Grigorian E.N., Grishanova A.Y., Iomdina E.N., Ivashchenko Z.h.N., Katargina L.A., Khoroshilova-Maslova I.P., Kilina O.V., Kolosova N.G., Kopenkin E.P., Korshunov S.S., Kovaleva N.A., Novikova Y.P., Philippov P.P., Pilipenko D.I., Robustova O.V., Saprunova V.B., Senin I.I., Skulachev M.V., Sotnikova L.F., Stefanova N.A., Tikhomirova N.K., Tsapenko I.V., Shchipanova A.I., Zinovkin R.A., and Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals. Biochemistry (Mosc.) 73 (2008) 1317-1328
41. Anisimov V.N., Bakeeva L.E., Egormin P.A., Filenko O.F., Isakova E.F., Manskikh V.N., Mikhelson V.M., Panteleeva A.A., Pasyukova E.G., Pilipenko D.I., Piskunova T.S., Popovich I.G., Roshchina N.V., Rybina O.Y., Saprunova V.B., Samoylova T.A., Semenchenko A.V., Skulachev M.V., Spivak I.M., Tsybul'ko E.A., Tyndyk M.L., Vyssokikh M.Y., Yurova M.N., Zabezhinsky M.A., and Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 5. SkQ1 prolongs lifespan and prevents development of traits of senescence. Biochemistry (Mosc.) 73 (2008) 1329-1342
42. Skulachev V.P., Anisimov V.N., Antonenko Y.N., Bakeeva L.E., Chernyak B.V., Erichev V.P., Filenko O.F., Kalinina N.I., Kapelko V.I., Kolosova N.G., Kopnin B.P., Korshunova G.A., Lichinitser M.R., Obukhova L.A., Pasyukova E.G., Pisarenko O.I., Roginsky V.A., Ruuge E.K., Senin I.I., Severina I.I., Skulachev M.V., Spivak I.M., Tashlitsky V.N., Tkachuk V.A., Vyssokikh M.Y., Yaguzhinsky L.S., and Zorov D.B. An attempt to prevent senescence: a mitochondrial approach. Biochim. Biophys. Acta 1787 (2009) 437-461
43. Plotnikov E.Y., Vasileva A.K., Arkhangelskaya A.A., Pevzner I.B., Skulachev V.P., and Zorov D.B. Interrelations of mitochondrial fragmentation and cell death under ischemia/reoxygenation and UV-irradiation: protective effects of SkQ1, lithium ions and insulin. FEBS Lett. 582 (2008) 3117-3124
44. Liu X., Kim C.N., Yang J., Jemmerson R., and Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86 (1996) 147-157
45. Zorov D.B., Filburn C.R., Klotz L.O., Zweier J.L., and Sollott S.J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 192 (2000) 1001-1014
46. Boveris A., and Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 134 (1973) 707-716
47. Kuzminova A.E., Zhuravlyova A.V., Vyssokikh M.Y.u., Zorova L.D., Krasnikov B.F., and Zorov D.B. The permeability transition pore induced under anaerobic conditions in mitochondria energized with ATP. FEBS Lett. 434 (1998) 313-316
48. Krasnikov B.F., Kuzminova A.E., and Zorov D.B. The Ca2+ -induced pore opening in mitochondria energized by succinate-ferricyanide electron transport. FEBS Lett. 419 (1997) 137-140
49. Zenebe W.J., Nazarewicz R.R., Parihar M.S., and Ghafourifar P. Hypoxia/reoxygenation of isolated rat heart mitochondria causes cytochrome c release and oxidative stress; evidence for involvement of mitochondrial nitric oxide synthase. J. Mol. Cell. Cardiol. 43 (2007) 411-419
50. Chander V., and Chopra K. Molsidomine, a nitric oxide donor and l-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure. Biochim. Biophys. Acta 1723 (2005) 208-214